Sectional detection of pathological processes of the female reproductive system in the presence of immunodeficiency states
PDF (Українська)

Keywords

HIV-infection
cervix
autopsy
opportunistic infection
tuberculosis

How to Cite

Lytvynenko, M. (2022). Sectional detection of pathological processes of the female reproductive system in the presence of immunodeficiency states. Experimental and Clinical Medicine, 91(2), 16-23. https://doi.org/10.35339/ekm.2022.91.2.lmv

Abstract

The presence of an immunodeficient state in women of reproductive age can lead to the development of comorbid pathology, including in the female reproductive system. Given the fairly frequent antisocial behavior of such women, timely diagnosis and early detection of lesions are not always possible or have significant drawbacks. Given the fairly frequent antisocial behavior of such women, timely diagnosis and early detection of lesions are not always possible or have significant disadvantages. Therefore, we set a goal to investigate how different the detection of pathological conditions of the female reproductive system is in the presence of HIV infection, chronic alcoholism, their simultaneous presence and their absence based on the results of cross-sectional studies. Autopsies of women with immunodeficiency of infectious and non-infectious origin were analyzed. According to the results, it was established that the presence of HIV infection, chronic alcoholism, and their combination is characterized by a more frequent development of pathological processes of an infectious nature, non-plastic remodeling, and non-specific inflammatory processes in the organs of the female reproductive system. Thus, it should be determined that female genital system requires close vigilance in the presence of immunodeficiency, taking into account the prevalence of this problem and its consequences.

Keywords: HIV-infection, cervix, autopsy, opportunistic infection, tuberculosis.

https://doi.org/10.35339/ekm.2022.91.2.lmv
PDF (Українська)

References

Tuano KS, Seth N, Chinen J. Secondary immunodeficiencies: An overview. Ann Al-lergy Asthma Immunol. 2021;127(6):617-26. DOI: 10.1016/j.anai.2021.08.413

Ballow M, Sanchez-Ramon S, Walter JE. Secondary Immune Deficiency and Prima-ry Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases. Front Immunol. 2022;13:928062. DOI: 10.3389/fimmu.2022.928062. PMID: 35924244.

Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159-66. DOI: 10.1007/s00038-009-0095-x. PMID: 19949966.

Rehm J, Probst C, Shield KD, Shuper PA. Does alcohol use have a causal effect on HIV incidence and disease progression? A review of the literature and a modeling strategy for quantifying the effect. Popul Health Metr. 2017;15(1):4. DOI: 10.1186/s12963-017-0121-9. PMID: 28183309.

Mendez-Ruiz MD, Villegas-Pantoja MA, Alarcón-Luna NS, Villegas N, Cianelli R, Peragallo-Montano N. Prevention of alcohol consumption and transmission of human immu-nodeficiency virus: randomized clinical trial. Rev Lat Am Enfermagem. 2020;28:e3262. DOI: 10.1590/1518-8345.3393.3262. PMID: 32401905.

Szabo G, Saha B. Alcohol's Effect on Host Defense. Alcohol Res. 2015;37(2):159-70. PMID: 26695755.

Lytvynenko M. Features of endometrial structure in alcohol-abused HIV-infected individuals. Inter Collegas. 2021;8(1):52-8. DOI: 10.35339/ic.8.1.52-58.

Lytvynenko MV. Tuberculosis of genitals in HIV-infected women. Inter Collegas. 2015;2(3):311-6. DOI: 10.35339/ic.2.3.311-316.

Woolf-King SE, Maisto SA. Alcohol use and high-risk sexual behavior in sub-Saharan Africa: a narrative review. Arch Sex Behav. 2011;40(1):17-42. DOI: 10.1007/s10508-009-9516-4. PMID: 19705274.

Bello B, Moultrie H, Somji A, Chersich MF, Watts C, Delany-Moretlwe S. Alcohol use and sexual risk behaviour among men and women in inner-city Johannesburg, South Af-rica. BMC Public Health. 2017;17(Suppl 3):548. DOI: 10.1186/s12889-017-4350-4. PMID: 28832283.

Gargin V, Radutny R, Titova G, Bibik D, Kirichenko A, Bazhenov O. Application of the computer vision system for evaluation of pathomorphological images. Proceedings of the 2020 IEEE 40th International Conference on Electronics and Nanotechnology (ELNANO). P. 469-73. DOI: 10.1109/ELNANO50318.2020.9088898.

Myers JL, Well AD. Research Design and Statistical Analysis (2nd ed.). USA: Lawrence Erlbaum Associates; 2003. 508 p.

Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, envi-ronmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287-323. DOI: 10.1016/S0140-6736(15)00128-2. PMID: 26364544.

Méndez-Samperio P. Diagnosis of Tuberculosis in HIV Co-infected Individuals: Current Status, Challenges and Opportunities for the Future. Scand J Immunol. 2017;86(2):76-82. DOI: 10.1111/sji.12567. PMID: 28513865.

Francini B, Cánepa MC, Lamonica C, Capece P, Posse G, Sanguineri V, et al. His-toplasmosis diseminada. Una infección oportunista en pacientes con infección por VIH. Ex-periencia en el Hospital Nacional Prof. A. Posadas, 2011-2017 [Disseminated histoplasmosis. An oportunistic infection in HIV positive patients Experience in the Hospital Nacional Prof. A. Posadas, 2011-2017]. Rev Chilena Infectol. 2018;35(6):671-9. DOI: 10.4067/S0716-10182018000600671. PMID: 31095188. [In Spanish].

Stepanova TV, Nedospasova OP, Golubchykov MV. Analysis of tuberculosis/HIV co-infection trends in Ukraine in 2008–2017. Wiad Lek. 2019;72(5 cz 1):903-7. PMID: 31175793.

Lytvynenko MV, Narbutova TY, Vasylyev VV, Gargin VV. Indicators of prolifera-tive activity of endometrium in women with immunodeficiency. Azerbaijan Med J. 2021(2):53-60. Available at: https://repo.odmu.edu.ua/xmlui/handle/123456789/11781

Munne KR, Tandon D, Chauhan SL, Patil AD. Female genital tuberculosis in light of newer laboratory tests: A narrative review. Indian J Tuberc. 2020 Jan;67(1):112-20. DOI: 10.1016/j.ijtb.2020.01.002. PMID: 32192604.

Borsa BA, Özgün G, Houbraken J, Ökmen F. İmmün kompetan bir hastada Asper-gillus protuberus'un neden olduğu ilk inatçı vajinit olgusu [The first case of persistent vagini-tis due to Aspergillus protuberus in an immunocompetent patient]. Mikrobiyol Bul. 2015;49(1):130-4. DOI: 10.5578/mb.8397. PMID: 25706739. [In Turkish].

Gupta P, Goyal S, Kaushal M. Concomitant Aspergillus Species Infection and Squamous Cell Carcinoma Diagnosed on Pap Smear. Turk Patoloji Derg. 2016;32(1):54-6. DOI: 10.5146/tjpath.2013.01198. PMID: 24272933.

Rojas Rojas T, Poizot-Martin I, Rey D, Duvivier C, Bani-Sadr F, Cabie A, et al. In-cidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France. PLoS One. 2022;17(3):e0261069. DOI: 10.1371/journal.pone.0261069. PMID: 35333883.

Grabar S, Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, et al. Inva-sive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study. HIV Med. 2019;20(3):222-9. DOI: 10.1111/hiv.12703. PMID: 30693646.

Cervical cancer facts. WHO, 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer

Kahesa C, Mwaiselage J, Wabinga HR, Ngoma T, Kalyango JN, Karamagi CA. As-sociation between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BMC Public Health. 2008;8:262. DOI: 10.1186/1471-2458-8-262. PMID: 18664298.

Lytvynenko M, Shkolnikov V, Bocharova T, Sychova L, Gargin V. Peculiarities of proliferative activity of cervical squamous cancer in HIV infection. Georgian Med News. 2017;(270):10-5. PMID: 28972476.

Yu Y, Choi J, Lee MH, Kim K, Ryu HM, Han HW. Maternal disease factors asso-ciated with neonatal jaundice: a case-control study. BMC Pregnancy Childbirth. 2022;22(1):247. DOI: 10.1186/s12884-022-04566-6. PMID: 35331174.

Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen MRJ, Fischer A, et al. Ini-tial presenting manifestations in 16,486 patients with inborn errors of immunity include in-fections and noninfectious manifestations. J Allergy Clin Immunol. 2021;148(5):1332-41.e5. DOI:10.1016/j.jaci.2021.04.015. PMID: 33895260.

Fritz K, Morojele N, Kalichman S. Alcohol: the forgotten drug in HIV/AIDS. Lan-cet. 2010;376:398-400. DOI: 10.1016/S0140-6736(10)60884-7. PMID: 20650516.

Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papilloma-virus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geo-graphical region, histological type and year of publication. Int J Cancer. 2011;128(4):927-35. DOI: 10.1002/ijc.25396. PMID: 20473886.

Nicol AF, Fernandes AT, Grinsztejn B, Russomano F, E Silva JR, Tristao A, et al. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection. Diagn Mol Pathol. 2005;14(1):39-47. DOI: 10.1097/01.pas.0000143309.81183.6c. PMID: 15714063.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.